888 related articles for article (PubMed ID: 34210406)
1. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
Barnett BS; Greer GR
J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
[TBL] [Abstract][Full Text] [Related]
2. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
Barnett BS; Parker SE; Weleff J
Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
[TBL] [Abstract][Full Text] [Related]
3. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
[TBL] [Abstract][Full Text] [Related]
4. Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
[TBL] [Abstract][Full Text] [Related]
5. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D
Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287
[TBL] [Abstract][Full Text] [Related]
6. The Past and Future of Psychedelic Science: An Introduction to This Issue.
Doblin RE; Christiansen M; Jerome L; Burge B
J Psychoactive Drugs; 2019; 51(2):93-97. PubMed ID: 31132970
[TBL] [Abstract][Full Text] [Related]
7. Older adults in psychedelic-assisted therapy trials: A systematic review.
Bouchet L; Sager Z; Yrondi A; Nigam KB; Anderson BT; Ross S; Petridis PD; Beaussant Y
J Psychopharmacol; 2024 Jan; 38(1):33-48. PubMed ID: 38240068
[TBL] [Abstract][Full Text] [Related]
8. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
Barnett BS; Beaussant Y; King F; Doblin R
J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
[TBL] [Abstract][Full Text] [Related]
10. Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
Barnett BS; Ziegler K; Doblin R; Carlo AD
J Psychopharmacol; 2022 Oct; 36(10):1118-1128. PubMed ID: 35971893
[TBL] [Abstract][Full Text] [Related]
11. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.
Johnston CB; Mangini M; Grob C; Anderson B
Am J Geriatr Psychiatry; 2023 Jan; 31(1):44-53. PubMed ID: 36184377
[TBL] [Abstract][Full Text] [Related]
12. Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.
Breeksema JJ; Kuin BW; Kamphuis J; van den Brink W; Vermetten E; Schoevers RA
J Psychopharmacol; 2022 Oct; 36(10):1100-1117. PubMed ID: 36017784
[TBL] [Abstract][Full Text] [Related]
13. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
[TBL] [Abstract][Full Text] [Related]
14. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.
Tabaac BJ; Shinozuka K; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
Am J Ther; 2024 Mar-Apr 01; 31(2):e97-e103. PubMed ID: 38518266
[TBL] [Abstract][Full Text] [Related]
15. Psychedelic drugs for psychiatric disorders.
da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
[TBL] [Abstract][Full Text] [Related]
16. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.
Inserra A; De Gregorio D; Gobbi G
Pharmacol Rev; 2021 Jan; 73(1):202-277. PubMed ID: 33328244
[TBL] [Abstract][Full Text] [Related]
17. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
Holoyda B
Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
[TBL] [Abstract][Full Text] [Related]
18. Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.
Fogg C; Michaels TI; de la Salle S; Jahn ZW; Williams MT
Exp Clin Psychopharmacol; 2021 Oct; 29(5):539-554. PubMed ID: 34096755
[TBL] [Abstract][Full Text] [Related]
19. The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky TG; Jagodnik KM; Barsic R; Antonio JH; Bonanno PA; MacLeod C; Pierce C; Carney H; Morrison MT; Saylor C; Danias G; Lepow L; Yehuda R
Curr Neuropharmacol; 2024; 22(4):636-735. PubMed ID: 38284341
[TBL] [Abstract][Full Text] [Related]
20. Psychedelic drugs-a new era in
psychiatry?
.
Nutt D
Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
